Navigation Links
Advanced Life Sciences Announces Plan to Submit NDA for Cethromycin
Date:4/10/2008

CHICAGO, April 10 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS), today announced that, based on a productive meeting with the U.S. Food and Drug Administration (FDA), the Company plans to submit a New Drug Application (NDA) in the third quarter of 2008 for its novel once-a-day oral antibiotic, cethromycin, to treat mild-to-moderate community acquired pneumonia (CAP).

(Logo: http://www.newscom.com/cgi-bin/prnh/20080218/ALSLOGO)

"We are pleased with the outcome of the meeting because it allows us to remain on track with our NDA submission goal," said Dr. Michael T. Flavin, chief executive officer of Advanced Life Sciences. "In addition, we believe that achieving this milestone will enable our partnership discussions to continue toward a conclusion in a timely manner."

During the meeting, FDA officials agreed that the Company could submit the NDA for cethromycin to treat mild-to-moderate CAP based on the pivotal Phase 3 trial results previously reported. The FDA will review any submission the Company makes to determine whether it meets the requirements for filing. There can be no assurance that the FDA will file the NDA, or that once filed, it will be approved.

Conference Call Details

The Company will host a conference call and live webcast today, Thursday, April 10, 2008, at 8:30 am (EDT). The focus of the call will be to discuss the planned NDA submission for the Company's novel once-a-day oral antibiotic, cethromycin, as a treatment for mild-to-moderate CAP.

The conference call will be webcast simultaneously over the Internet. Please visit the Investor Relations section of the Advanced
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
3. Advanced Cell Technology Announces Proposed Financing
4. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
5. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
6. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
7. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
8. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
9. Advanced Bionics Deploys CEVA-TeakLite(TM) DSP Core to Enhance Its Harmony(TM) HiResolution(R) Bionic Ear System
10. NIH Announces Advanced Cell Technologys Single Cell Embryo Biopsy Technique as a Means to Derive Embryonic Stem Cells to be Considered for Federal Funding
11. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... CIO Review ( http://www.cioreview.com ) has chosen ... Pharma and Life Science Technology Solution Providers 2015. The ... platform for life sciences companies. , The annual ... experts and members of CIO Review’s editorial board to ... been on our radar for some time now for ...
(Date:4/17/2015)... , April 17, 2015  US-Australian drug discovery company, ... Memorandum of Understanding with the Feinstein Institute for ... York to collaborate with the objective ... The collaboration brings together the drug discovery ... expertise of the Feinstein Institute in neurosciences and ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 BellBrook ... and marketing support for the powerful Orthogonal Pooled ... Chemical Genomics Center at the Lankenau Institute for ... mission is to measurably improve successful drug discovery ... by offering rare, drug-like libraries available nowhere else, ...
(Date:4/16/2015)... (PRWEB) April 16, 2015 ... data solutions driven by Semantic Web technology, and ... specialist information and services for the academic and ... that its joint solution ‘Smart Data Lake for ... finalist for the 2015 Bio-IT ‘Best of Show’ ...
Breaking Biology Technology:MMIS Chosen by CIO Review as Top 20 Most Promising Pharma and Life Science Technology Solution Providers 2015 2Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 2Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 3Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 4Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 5Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 6BellBrook Labs and Lankenau Institute Partner to Accelerate Drug Discovery using Orthogonal Pooled Screening 2Cambridge Semantics and Informa Named Bio-IT Award Finalist for Smart Data Lake Solution for Clinical Trial and Competitive Intelligence 2Cambridge Semantics and Informa Named Bio-IT Award Finalist for Smart Data Lake Solution for Clinical Trial and Competitive Intelligence 3
... (Euronext: AMT), a leader in the field of ... first patient in a preregistration,clinical trial with Glybera(TM). ... a seriously debilitating and,potentially lethal disease. , ... been designed to gather additional,data on the effects ...
... Call Scheduled for May 7, 2009 at 10:00 a.m. EDT ... SVNT ) today reported financial results for the three ... 2009, the Company had a net loss of $21.9 million, or ... million compared with a net loss of $17.6 million, or $0.33 ...
... First Quarter Highlights , , , ... the first quarter of 2008 , ... of 2008 , Saflex and Technical ... The Company,s cash generation in the quarter allowed for debt reduction of ...
Cached Biology Technology:AMT Starts Preregistration Trial for Glybera(TM) 2AMT Starts Preregistration Trial for Glybera(TM) 3Savient Pharmaceuticals Reports First Quarter 2009 Financial Results 2Savient Pharmaceuticals Reports First Quarter 2009 Financial Results 3Savient Pharmaceuticals Reports First Quarter 2009 Financial Results 4Savient Pharmaceuticals Reports First Quarter 2009 Financial Results 5Savient Pharmaceuticals Reports First Quarter 2009 Financial Results 6Savient Pharmaceuticals Reports First Quarter 2009 Financial Results 7Savient Pharmaceuticals Reports First Quarter 2009 Financial Results 8Savient Pharmaceuticals Reports First Quarter 2009 Financial Results 9Solutia Reports First Quarter 2009 Results 2Solutia Reports First Quarter 2009 Results 3Solutia Reports First Quarter 2009 Results 4Solutia Reports First Quarter 2009 Results 5Solutia Reports First Quarter 2009 Results 6Solutia Reports First Quarter 2009 Results 7Solutia Reports First Quarter 2009 Results 8Solutia Reports First Quarter 2009 Results 9Solutia Reports First Quarter 2009 Results 10Solutia Reports First Quarter 2009 Results 11Solutia Reports First Quarter 2009 Results 12Solutia Reports First Quarter 2009 Results 13Solutia Reports First Quarter 2009 Results 14Solutia Reports First Quarter 2009 Results 15Solutia Reports First Quarter 2009 Results 16Solutia Reports First Quarter 2009 Results 17Solutia Reports First Quarter 2009 Results 18Solutia Reports First Quarter 2009 Results 19Solutia Reports First Quarter 2009 Results 20Solutia Reports First Quarter 2009 Results 21
(Date:3/24/2015)... 24, 2015   Crossmatch ™, a leading ... that its U.are.U ® 4500 Fingerprint Readers ... Bros . to achieve PCI compliance for Point-of-Sale ... to the POS terminal, protecting the retailer and ... breaches. With one-third of worldwide ...
(Date:3/20/2015)... 20, 2015 Research and Markets ... the "India Sensors Market Forecast and Opportunities ... The sensor market is projected to grow at ... Consumer electronics, automotive, industrial and healthcare sectors are ... country. In addition, adoption of MEMS technology in ...
(Date:3/18/2015)... -- As mobile payments become more prevalent amongst ... apps continue to be introduced into the market place at ... industry in focus today are:  NXT-ID, Inc. (NASDAQ: ... ), Apple Inc. (NASDAQ: AAPL ), Google Inc. ... FB ) NXT-ID, Inc. (NASDAQ: ...
Breaking Biology News(10 mins):Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 2Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 3Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 4Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 5Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 6
... cells and those two cells divide into four more daughters, ... have long assumed, is an eternally youthful population of bacteria. ... in the same way all other organisms do. But ... California, San Diego questions that longstanding paradigm. In a paper ...
... the global media speculate on the number of people likely ... of population and development experts argue that it is not ... their distribution by age, education, health status and location that ... realistic attempt to achieve sustainable development must focus primarily on ...
... and Bristol, in partnership with Rothamsted Research have officially ... facing humanity: how can we sustainably feed a growing ... launched at the House of Commons on 26 October ... brink of reaching seven billion. The Alliance brings ...
Cached Biology News:Do bacteria age? Biologists discover the answer follows simple economics 2Do bacteria age? Biologists discover the answer follows simple economics 37 billion people are not the issue - human development is what counts 27 billion people are not the issue - human development is what counts 3UK scientists come together to help feed the 7 billion 2UK scientists come together to help feed the 7 billion 3UK scientists come together to help feed the 7 billion 4UK scientists come together to help feed the 7 billion 5
...
... Comments: Ab-1 stains tumor cells ... not other type of germ cell tumors like ... immature teratoma are positive. Luminal and endocrine cells ... lobules of breast are also positive. ...
TP-1 (NDOG1)...
Ras-related C3 botulinum toxin substrate 1...
Biology Products: